# Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease

> **NCT06014320** · — · UNKNOWN · sponsor: **Stanford University** · enrollment: 25 (estimated)

## Conditions studied

- Liver Cirrhosis
- Hemophilia
- Hemophilia A
- Hemophilia B
- Liver Transplant Disorder
- Liver Failure
- Coagulation Factor Deficiency

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06014320
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2024-04-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2023-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06014320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06014320, "Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06014320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*